BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 26365985)

  • 1. Associations among pretreatment tumor necrosis and the expression of HIF-1α and PD-L1 in advanced oral squamous cell carcinoma and the prognostic impact thereof.
    Chen TC; Wu CT; Wang CP; Hsu WL; Yang TL; Lou PJ; Ko JY; Chang YL
    Oral Oncol; 2015 Nov; 51(11):1004-1010. PubMed ID: 26365985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High co-expression of PD-L1 and HIF-1α correlates with tumour necrosis in pulmonary pleomorphic carcinoma.
    Chang YL; Yang CY; Lin MW; Wu CT; Yang PC
    Eur J Cancer; 2016 Jun; 60():125-35. PubMed ID: 27107327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexpression of hypoxia-inducible factor-1α and glucose transporter-1 is associated with poor prognosis in oral squamous cell carcinoma patients.
    Eckert AW; Lautner MH; Schütze A; Taubert H; Schubert J; Bilkenroth U
    Histopathology; 2011 Jun; 58(7):1136-47. PubMed ID: 21438910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant association of increased PD-L1 and PD-1 expression with nodal metastasis and a poor prognosis in oral squamous cell carcinoma.
    Maruse Y; Kawano S; Jinno T; Matsubara R; Goto Y; Kaneko N; Sakamoto T; Hashiguchi Y; Moriyama M; Toyoshima T; Kitamura R; Tanaka H; Oobu K; Kiyoshima T; Nakamura S
    Int J Oral Maxillofac Surg; 2018 Jul; 47(7):836-845. PubMed ID: 29395669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of hypoxia-inducible factor 1α is associated with lymph node metastasis in oral squamous cell carcinoma].
    Li JN; Feng ZE; Wang L; Wang YX; Guo CB
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Feb; 50(1):26-32. PubMed ID: 29483718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is There Evidence for the Presence and Relevance of the PD-1/PD-L1 Pathway in Oral Squamous Cell Carcinoma? Hints From an Immunohistochemical Study.
    Troeltzsch M; Woodlock T; Pianka A; Otto S; Troeltzsch M; Ehrenfeld M; Knösel T
    J Oral Maxillofac Surg; 2017 May; 75(5):969-977. PubMed ID: 27916470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and prognostic significance of HIF-1α overexpression in oral squamous cell carcinoma: a meta-analysis.
    Zhou J; Huang S; Wang L; Yuan X; Dong Q; Zhang D; Wang X
    World J Surg Oncol; 2017 May; 15(1):104. PubMed ID: 28521842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia inducible factor 1α and hypoxia inducible factor 2α play distinct and functionally overlapping roles in oral squamous cell carcinoma.
    Zhu GQ; Tang YL; Li L; Zheng M; Jiang J; Li XY; Chen SX; Liang XH
    Clin Cancer Res; 2010 Oct; 16(19):4732-41. PubMed ID: 20807755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia inducible factor-alpha expression correlates with vascular endothelial growth factor-C expression and lymphangiogenesis/angiogenesis in oral squamous cell carcinoma.
    Liang X; Yang D; Hu J; Hao X; Gao J; Mao Z
    Anticancer Res; 2008; 28(3A):1659-66. PubMed ID: 18630523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PD-L1 Expression in Tumor Cells Is an Independent Unfavorable Prognostic Factor in Oral Squamous Cell Carcinoma.
    de Vicente JC; Rodríguez-Santamarta T; Rodrigo JP; Blanco-Lorenzo V; Allonca E; García-Pedrero JM
    Cancer Epidemiol Biomarkers Prev; 2019 Mar; 28(3):546-554. PubMed ID: 30487133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of nuclear p-mTOR expression in advanced oral squamous cell carcinoma with extracapsular extension of lymph node metastases.
    Chen TC; Wu CT; Wang CP; Yang TL; Lou PJ; Ko JY; Chang YL
    Oral Oncol; 2015 May; 51(5):493-9. PubMed ID: 25769791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PD-L1 Expression Confers Better Prognosis in Locally Advanced Oral Squamous Cell Carcinoma.
    Kogashiwa Y; Yasuda M; Sakurai H; Nakahira M; Sano Y; Gonda K; Ikeda T; Inoue H; Kuba K; Oba S; Ishikawa J; Enoki Y; Matsumura S; Minami K; Ebihara Y; Sugasawa M
    Anticancer Res; 2017 Mar; 37(3):1417-1424. PubMed ID: 28314313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between the expressions of PD-L1 and tumor-infiltrating lymphocytes in oral squamous cell carcinoma.
    Cho YA; Yoon HJ; Lee JI; Hong SP; Hong SD
    Oral Oncol; 2011 Dec; 47(12):1148-53. PubMed ID: 21911310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression patterns through oral squamous cell carcinoma development: PD-L1 expression in primary tumor and circulating tumor cells.
    Oliveira-Costa JP; de Carvalho AF; da Silveira da GG; Amaya P; Wu Y; Park KJ; Gigliola MP; Lustberg M; Buim ME; Ferreira EN; Kowalski LP; Chalmers JJ; Soares FA; Carraro DM; Ribeiro-Silva A
    Oncotarget; 2015 Aug; 6(25):20902-20. PubMed ID: 26041877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of immunoregulatory molecules PD-L1 and PD-1 in oral cancer and precancerous lesions: A cohort study of Japanese patients.
    Kouketsu A; Sato I; Oikawa M; Shimizu Y; Saito H; Takahashi T; Kumamoto H
    J Craniomaxillofac Surg; 2019 Jan; 47(1):33-40. PubMed ID: 30466788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of programmed death-1 and its ligand, programmed death ligand-1 in oral squamous cell carcinoma with and without oral submucous fibrosis.
    Quan H; Liu S; Shan Z; Liu Z; Chen T; Hu Y; Yao Z; Fang L
    Arch Oral Biol; 2020 Nov; 119():104916. PubMed ID: 32977151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Siah-1 is associated with expression of hypoxia-inducible factor-1α in oral squamous cell carcinoma.
    Aga M; Kondo S; Wakisaka N; Moriyama-Kita M; Endo K; Nakanishi Y; Murono S; Sugimoto H; Ueno T; Yoshizaki T
    Auris Nasus Larynx; 2017 Apr; 44(2):213-219. PubMed ID: 27616748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of hypoxia-inducible factor-1 alpha is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
    Lin PY; Yu CH; Wang JT; Chen HH; Cheng SJ; Kuo MY; Chiang CP
    J Oral Pathol Med; 2008 Jan; 37(1):18-25. PubMed ID: 18154573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Programmed cell death-ligand 1 expression is associated with a favourable immune microenvironment and better overall survival in stage I pulmonary squamous cell carcinoma.
    Yang CY; Lin MW; Chang YL; Wu CT; Yang PC
    Eur J Cancer; 2016 Apr; 57():91-103. PubMed ID: 26901614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmed cell death-ligand 1 expression in oral squamous cell carcinoma is associated with an inflammatory phenotype.
    Satgunaseelan L; Gupta R; Madore J; Chia N; Lum T; Palme CE; Boyer M; Scolyer RA; Clark JR
    Pathology; 2016 Oct; 48(6):574-80. PubMed ID: 27590194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.